Integrated Drug Development, the Certara Way

Customer First Focus

Your success is our guiding principle. Trusted by over 1,650 active customers across 60 countries, we are members of your team.

We design and implement drug development strategies using quantitative science and an integrated approach to:

  • Get to proof of concept faster
  • Optimize trial design
  • Reduce trial size or avoid certain trials altogether
  • Expedite regulatory submissions
  • Expand patient access to medicines
Uncompromising Quality

The high quality of our work is the result of dedication, collaboration, and deep expertise.

By choosing to partner with Certara, you tap into the expertise and insights of over 650 leading drug development, regulatory, and market access experts who are committed to finding the right answers and increasing the probability of your success.

We navigate complexity through flawless execution and stewardship with our top scientists and experts in pursuit of your goals.

 

Our History

In 2008, Tripos International and Pharsight Corporation came together to form Certara. Since then, we have achieved incredible growth through thirteen acquisitions and the adoption of model-informed drug development by industry and regulatory agencies.

Today, we are the global leader in biosimulation. Our quantitative science approach and unique portfolio of software and services that span the entire lifecycle accelerate medicines to patients, in concert with you.

We will continue expanding boundaries to make the drug development process more efficient and medicines safer and better for patients.

How can we help you?
Start a conversation with us